Representative before the EPO

Employment test 11 - 50 employees
Company dna katzarov sa
operating since 1967
705.65
Headquarter in Genève and 1 office
active in Legal Services and IP Consulting

We have observed 1 EP application Gilles Pfend has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11745516

USE OF A PEPTIDE ENHANCING THE ABILITY OF RADIATION THERAPY TO KILL CANCER CELLS

IPC classification:
A61K 38/17, A61K 47/48, A61N 5/10, A61P 35/00
Applicant:
University of Lausanne (Université de Lausanne)
Agent:
Gilles Pfend, Katzarov SA
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature